Kanahara Masaaki, Kai Hisashi, Okamura Takashi, Wada Toyofumi, Suda Kenji, Imaizumi Tsutomu, Sagawa Kimitaka
Department of Laboratory Medicine, Kurume University Hospital, Kurume, Japan.
Thromb Res. 2008;121(6):781-5. doi: 10.1016/j.thromres.2007.08.004. Epub 2007 Oct 1.
Pseudoprolongation of activated partial thromboplastin time (APTT) is a serious problem in anticoagulation therapy for patients with high hematocrit, such as cyanotic congenital heart diseases. APTT pseudoprolongation occurs when APTT assay is performed using routinely used vacuum sampling tubes containing citrate. Because the plasma fraction is small in high-hematocrit blood, the prescribed volume of citrate would be excessive for APTT assay, resulting in prolongation of clotting or APTT pseudoprolongation. CLSI--The Clinical and Laboratory Standards Institute (formerly NCCLS) method is the established method to correct the pseudoprolongation. However, the CLSI method needs repeated blood drawings and time-consuming, complicate procedures. Thus, alternative simple method is desired.
We examined whether APTT pseudoprolongation would be prevented by the increase in free calcium ion concentration by using high-concentration calcium chloride solution for the assay. Blood samples were obtained from 15 patients with high hematocrit (65+/-6%) who had cyanotic congenital heart disease.
Conventional APTT assay using 0.025 mol/L calcium chloride solution gave greater APTT compared with the CLSI method (51.7+/-11.8 vs. 34.6+/-4.7 s, p<0.001). However, when 0.035 mol/L calcium chloride solution was used, APTT (36.6+/-5.8 s) was similar to that obtained from the CLSI method. There was a good correlation in APTT values between high-calcium chloride solution method and the CLSI method (the slope=0.57, r2=0.49).
High-calcium chloride solution method is useful to correct APTT pseudoprolongation. Because of the simplicity and the need of a single blood drawing, this method would reduce the burdens of not only patients but also clinical laboratory.
活化部分凝血活酶时间(APTT)假性延长是血细胞比容高的患者(如紫绀型先天性心脏病患者)抗凝治疗中的一个严重问题。当使用常规含枸橼酸盐的真空采样管进行APTT检测时,就会出现APTT假性延长。由于高血细胞比容血液中的血浆部分较少,用于APTT检测的规定枸橼酸盐体积会过多,导致凝血时间延长或APTT假性延长。CLSI(临床和实验室标准协会,前身为NCCLS)方法是纠正假性延长的既定方法。然而,CLSI方法需要反复抽血且程序耗时、复杂。因此,需要替代的简单方法。
我们研究了通过在检测中使用高浓度氯化钙溶液增加游离钙离子浓度是否能防止APTT假性延长。从15名血细胞比容高(65±6%)的紫绀型先天性心脏病患者中采集血样。
与CLSI方法相比,使用0.025 mol/L氯化钙溶液的传统APTT检测得出的APTT更长(51.7±11.8对34.6±4.7秒,p<0.001)。然而,当使用0.035 mol/L氯化钙溶液时,APTT(36.6±5.8秒)与CLSI方法得到的结果相似。高氯化钙溶液法与CLSI法的APTT值之间存在良好的相关性(斜率=0.57,r2=0.49)。
高氯化钙溶液法可有效纠正APTT假性延长。由于该方法简单且只需一次抽血,它不仅能减轻患者负担,也能减轻临床实验室的负担。